GENZ, BMRN down in front of PDUFA date

BioMarin (BMRN; SWX:BMRN) and partner Genzyme (GENZ) both were down slightly in front of Tuesday's PDUFA deadline for their Aldurazyme to treat mucopolysaccharidosis I (MPS I). BMRN was off $0.55 to $...